Chemoinformaics analysis of Vanillyl beta-D-glucopyranoside
Molecular Weight | 316.306 | nRot | 5 |
Heavy Atom Molecular Weight | 296.146 | nRig | 12 |
Exact Molecular Weight | 316.116 | nRing | 2 |
Solubility: LogS | -0.882 | nHRing | 1 |
Solubility: LogP | -1.253 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
nHA | 8 | APOL | 43.1319 |
nHD | 5 | BPOL | 25.2721 |
QED | 0.454 |
Synth | 3.422 |
Natural Product Likeliness | 1.781 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.061 |
HIA | 0.89 |
CACO-2 | -5.411 |
MDCK | 0.000422479 |
BBB | 0.648 |
PPB | 0.233834 |
VDSS | 0.718 |
FU | 0.691011 |
CYP1A2-inh | 0.016 |
CYP1A2-sub | 0.096 |
CYP2c19-inh | 0.013 |
CYP2c19-sub | 0.606 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.44 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.311 |
CYP3a4-inh | 0.005 |
CYP3a4-sub | 0.037 |
CL | 2.257 |
T12 | 0.709 |
hERG | 0.049 |
Ames | 0.531 |
ROA | 0.066 |
SkinSen | 0.05 |
Carcinogencity | 0.087 |
EI | 0.013 |
Respiratory | 0.021 |
NR-Aromatase | 0.021 |
Antiviral | Yes |
Prediction | 0.812925 |